U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594483) titled 'Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium' on May 08.
Brief Summary: The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder
Intervention:
DEVICE: Motif XCS System
The Motif XCS System is a programmable device that delivers stimulation through surface electrodes implanted in a burr hole in the skull, positioned over the left dorsola...